Overcoming adaptive therapy resistance in AML by targeting immune response pathwaysKatelyn Melgar, Daniel T. Starczynowski, James C. Mulloy et al.|Science Translational Medicine|2019Cited by 88
The cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiationBenjamin Mizukawa, Yi Zheng, H. Leighton Grimes et al.|Blood|2017Cited by 46